biosperse 535c - cooling tower services nz ltd 535c.pdfurgent hospital treatment is likely to be...

14
Solenis New Zealand Ltd Chemwatch Hazard Alert Code: 3 BIOSPERSE 535C Chemwatch: 80-2944 Version No: 2.1.1.1 Safety Data Sheet according to HSNO Regulations Issue Date: 05/05/2017 Print Date: 04/07/2017 L.GHS.NZL.EN SECTION 1 IDENTIFICATION OF THE SUBSTANCE / MIXTURE AND OF THE COMPANY / UNDERTAKING Product Identifier Product name BIOSPERSE 535C Proper shipping name ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S. Other means of identification Not Available Relevant identified uses of the substance or mixture and uses advised against Relevant identified uses Microbiocide additive. Details of the supplier of the safety data sheet Registered company name Solenis New Zealand Ltd Address 119 Carbine Rd, PO Box 132-347 Auckland 1644 New Zealand Telephone 64 9 276 6620 Fax 64 9 276 6690 Website Solenis.com Email [email protected] Emergency telephone number Association / Organisation Chemwatch Emergency telephone numbers 0080024362255 Other emergency telephone numbers Not Available SECTION 2 HAZARDS IDENTIFICATION Classification of the substance or mixture Considered a Hazardous Substance according to the criteria of the New Zealand Hazardous Substances New Organisms legislation. Classified as Dangerous Goods for transport purposes. CHEMWATCH HAZARD RATINGS Max Min Flammability 0 Toxicity 2 Body Contact 3 Reactivity 1 Chronic 3 0 = Minimum 1 = Low 2 = Moderate 3 = High 4 = Extreme Classification [1] Acute Toxicity (Oral) Category 4, Acute Toxicity (Dermal) Category 4, Serious Eye Damage Category 1, Skin Sensitizer Category 1, Reproductive Toxicity Category 1A, Acute Aquatic Hazard Category 1, Chronic Aquatic Hazard Category 1 Continued...

Upload: others

Post on 11-Nov-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: BIOSPERSE 535C - Cooling Tower Services NZ Ltd 535C.pdfUrgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following

Solenis New Zealand Ltd Chemwatch Hazard Alert Code: 3

BIOSPERSE 535C

Chemwatch: 80-2944

Version No: 2.1.1.1

Safety Data Sheet according to HSNO Regulations

Issue Date: 05/05/2017

Print Date: 04/07/2017

L.GHS.NZL.EN

SECTION 1 IDENTIFICATION OF THE SUBSTANCE / MIXTURE AND OF THE COMPANY / UNDERTAKING

Product Identifier

Product name BIOSPERSE 535C

Proper shipping name ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S.

Other means ofidentification

Not Available

Relevant identified uses of the substance or mixture and uses advised against

Relevant identifieduses

Microbiocide additive.

Details of the supplier of the safety data sheet

Registered companyname

Solenis New Zealand Ltd

Address 119 Carbine Rd, PO Box 132-347 Auckland 1644 New Zealand

Telephone 64 9 276 6620

Fax 64 9 276 6690

Website Solenis.com

Email [email protected]

Emergency telephone number

Association /Organisation

Chemwatch

Emergency telephonenumbers

0080024362255

Other emergencytelephone numbers

Not Available

SECTION 2 HAZARDS IDENTIFICATION

Classification of the substance or mixture

Considered a Hazardous Substance according to the criteria of the New Zealand Hazardous Substances New Organisms legislation.Classified as Dangerous Goods for transport purposes.

CHEMWATCH HAZARD RATINGS

MaxMin

Flammability 0Toxicity 2  Body Contact 3  Reactivity 1  Chronic 3  

0 = Minimum1 = Low2 = Moderate3 = High4 = Extreme

Classification [1] Acute Toxicity (Oral) Category 4, Acute Toxicity (Dermal) Category 4, Serious Eye Damage Category 1, Skin SensitizerCategory 1, Reproductive Toxicity Category 1A, Acute Aquatic Hazard Category 1, Chronic Aquatic Hazard Category 1

Continued...

Page 2: BIOSPERSE 535C - Cooling Tower Services NZ Ltd 535C.pdfUrgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following

Legend:1. Classified by Chemwatch; 2. Classification drawn from CCID EPA NZ ; 3. Classification drawn from EC Directive 1272/2008 -Annex VI

Determined byChemwatch using

GHS/HSNO criteria6.1D (dermal), 6.1D (oral), 6.5B (contact), 6.8A, 8.3A, 9.1A

Label elements

Hazard pictogram(s)

SIGNAL WORD DANGER

Hazard statement(s)

H302 Harmful if swallowed.

H312 Harmful in contact with skin.

H318 Causes serious eye damage.

H317 May cause an allergic skin reaction.

H360 May damage fertility or the unborn child.

H410 Very toxic to aquatic life with long lasting effects.

Precautionary statement(s) Prevention

P201 Obtain special instructions before use.

P280 Wear protective gloves/protective clothing/eye protection/face protection.

P281 Use personal protective equipment as required.

P261 Avoid breathing mist/vapours/spray.

P270 Do not eat, drink or smoke when using this product.

P273 Avoid release to the environment.

P272 Contaminated work clothing should not be allowed out of the workplace.

Precautionary statement(s) Response

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P308+P313 IF exposed or concerned: Get medical advice/attention.

P310 Immediately call a POISON CENTER or doctor/physician.

P363 Wash contaminated clothing before reuse.

P302+P352 IF ON SKIN: Wash with plenty of soap and water.

P333+P313 If skin irritation or rash occurs: Get medical advice/attention.

P391 Collect spillage.

P301+P312 IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.

P330 Rinse mouth.

Precautionary statement(s) Storage

P405 Store locked up.

Precautionary statement(s) Disposal

P501 Dispose of contents/container in accordance with local regulations.

SECTION 3 COMPOSITION / INFORMATION ON INGREDIENTS

SubstancesSee section below for composition of Mixtures

Mixtures

Chemwatch: 80-2944

Version No: 2.1.1.1

Page 2 of 14

BIOSPERSE 535C

Issue Date: 05/05/2017

Print Date: 04/07/2017

Continued...

Page 3: BIOSPERSE 535C - Cooling Tower Services NZ Ltd 535C.pdfUrgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following

CAS No %[weight] Name

55566-30-8 20-40

7732-18-5 >60

SECTION 4 FIRST AID MEASURES

NZ Poisons Centre 0800 POISON (0800 764 766) | NZ Emergency Services: 111

Description of first aid measures

Eye Contact

If this product comes in contact with the eyes: Immediately hold eyelids apart and flush the eye continuously with running water. Ensure complete irrigation of the eye by keeping eyelids apart and away from eye and moving the eyelids by occasionallylifting the upper and lower lids. Continue flushing until advised to stop by the Poisons Information Centre or a doctor, or for at least 15 minutes. Transport to hospital or doctor without delay. Removal of contact lenses after an eye injury should only be undertaken by skilled personnel. 

Skin Contact

If skin contact occurs:Immediately remove all contaminated clothing, including footwear. Flush skin and hair with running water (and soap if available). Seek medical attention in event of irritation. 

Inhalation

If fumes or combustion products are inhaled remove from contaminated area. Lay patient down. Keep warm and rested. Prostheses such as false teeth, which may block airway, should be removed, where possible, prior to initiating first aidprocedures. Apply artificial respiration if not breathing, preferably with a demand valve resuscitator, bag-valve mask device, or pocketmask as trained. Perform CPR if necessary. Transport to hospital, or doctor. 

Ingestion

IF SWALLOWED, REFER FOR MEDICAL ATTENTION, WHERE POSSIBLE, WITHOUT DELAY. For advice, contact a Poisons Information Centre or a doctor. Urgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following observation and employing supportivemeasures as indicated by the patient's condition. If the services of a medical officer or medical doctor are readily available, the patient should be placed in his/her care anda copy of the SDS should be provided. Further action will be the responsibility of the medical specialist. If medical attention is not available on the worksite or surroundings send the patient to a hospital together with a copy ofthe SDS. 

Where medical attention is not immediately available or where the patient is more than 15 minutes from a hospitalor unless instructed otherwise: 

INDUCE vomiting with fingers down the back of the throat, ONLY IF CONSCIOUS. Lean patient forward or place on leftside (head-down position, if possible) to maintain open airway and prevent aspiration. 

NOTE: Wear a protective glove when inducing vomiting by mechanical means.

Indication of any immediate medical attention and special treatment neededTreat symptomatically.

SECTION 5 FIREFIGHTING MEASURES

Extinguishing mediaThe product contains a substantial proportion of water, therefore there are no restrictions on the type of extinguishing media which may be used. Choiceof extinguishing media should take into account surrounding areas.Though the material is non-combustible, evaporation of water from the mixture, caused by the heat of nearby fire, may produce floating layers ofcombustible substances.In such an event consider:

foam. dry chemical powder. carbon dioxide. 

Special hazards arising from the substrate or mixture

Fire Incompatibility None known.

Advice for firefighters

tetrakis(hydroxymethyl)phosphonium sulfate

water

Chemwatch: 80-2944

Version No: 2.1.1.1

Page 3 of 14

BIOSPERSE 535C

Issue Date: 05/05/2017

Print Date: 04/07/2017

Continued...

Page 4: BIOSPERSE 535C - Cooling Tower Services NZ Ltd 535C.pdfUrgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following

Fire Fighting

Alert Fire Brigade and tell them location and nature of hazard. Wear breathing apparatus plus protective gloves in the event of a fire. Prevent, by any means available, spillage from entering drains or water courses. Use fire fighting procedures suitable for surrounding area. 

DO NOT approach containers suspected to be hot. Cool fire exposed containers with water spray from a protected location. If safe to do so, remove containers from path of fire. Equipment should be thoroughly decontaminated after use. 

Fire/Explosion Hazard

The material is not readily combustible under normal conditions. However, it will break down under fire conditions and the organic component may burn. Not considered to be a significant fire risk. Heat may cause expansion or decomposition with violent rupture of containers. Decomposes on heating and may produce toxic fumes of carbon monoxide (CO). May emit acrid smoke. 

Other decomposition products include:,carbon dioxide (CO2),phosphorus oxides (POx),sulfur oxides (SOx),other pyrolysis products typical of burning organic material.

SECTION 6 ACCIDENTAL RELEASE MEASURES

Personal precautions, protective equipment and emergency proceduresSee section 8

Environmental precautionsSee section 12

Methods and material for containment and cleaning up

Minor Spills

Environmental hazard - contain spillage. Clean up all spills immediately. Avoid breathing vapours and contact with skin and eyes. Control personal contact with the substance, by using protective equipment. Contain and absorb spill with sand, earth, inert material or vermiculite. Wipe up. Place in a suitable, labelled container for waste disposal. 

Major Spills

Clear area of personnel and move upwind. Alert Fire Brigade and tell them location and nature of hazard. Wear breathing apparatus plus protective gloves. Prevent, by any means available, spillage from entering drains or water course. Stop leak if safe to do so. Contain spill with sand, earth or vermiculite. Collect recoverable product into labelled containers for recycling. Neutralise/decontaminate residue (see Section 13 for specific agent). Collect solid residues and seal in labelled drums for disposal. Wash area and prevent runoff into drains. After clean up operations, decontaminate and launder all protective clothing and equipment before storing and re-using. If contamination of drains or waterways occurs, advise emergency services. 

Environmental hazard - contain spillage. 

Personal Protective Equipment advice is contained in Section 8 of the SDS.

SECTION 7 HANDLING AND STORAGE

Precautions for safe handling

Safe handling

DO NOT allow clothing wet with material to stay in contact with skinAvoid all personal contact, including inhalation. Wear protective clothing when risk of exposure occurs. Use in a well-ventilated area. Avoid contact with moisture. Avoid contact with incompatible materials. 

When handling, DO NOT eat, drink or smoke. Keep containers securely sealed when not in use. 

Chemwatch: 80-2944

Version No: 2.1.1.1

Page 4 of 14

BIOSPERSE 535C

Issue Date: 05/05/2017

Print Date: 04/07/2017

Continued...

Page 5: BIOSPERSE 535C - Cooling Tower Services NZ Ltd 535C.pdfUrgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following

Avoid physical damage to containers. Always wash hands with soap and water after handling. Work clothes should be laundered separately. Launder contaminated clothing before re-use. Use good occupational work practice. Observe manufacturer's storage and handling recommendations contained within this SDS.Atmosphere should be regularly checked against established exposure standards to ensure safe working conditions aremaintained. 

Other information

Store in original containers. Keep containers securely sealed. Store in a cool, dry, well-ventilated area. Store away from incompatible materials and foodstuff containers. Protect containers against physical damage and check regularly for leaks. Observe manufacturer's storage and handling recommendations contained within this SDS.

Conditions for safe storage, including any incompatibilities

Suitable container

Lined metal can, lined metal pail/ can. Plastic pail. Polyliner drum. Packing as recommended by manufacturer. Check all containers are clearly labelled and free from leaks. 

Storageincompatibility

Reacts with mild steel, galvanised steel / zinc producing hydrogen gas which may form an explosive mixture with air. 

SECTION 8 EXPOSURE CONTROLS / PERSONAL PROTECTION

Control parameters

OCCUPATIONAL EXPOSURE LIMITS (OEL)

INGREDIENT DATA

Not Available

EMERGENCY LIMITS

Ingredient Material name TEEL-1 TEEL-2 TEEL-3

BIOSPERSE 535C Not Available Not Available Not Available Not Available

Ingredient Original IDLH Revised IDLH

tetrakis(hydroxymethyl)phosphoniumsulfate

Not Available Not Available

water Not Available Not Available

MATERIAL DATA

Exposure controls

Appropriateengineering controls

Engineering controls are used to remove a hazard or place a barrier between the worker and the hazard. Well-designedengineering controls can be highly effective in protecting workers and will typically be independent of worker interactions toprovide this high level of protection.The basic types of engineering controls are:Process controls which involve changing the way a job activity or process is done to reduce the risk.Enclosure and/or isolation of emission source which keeps a selected hazard "physically" away from the worker andventilation that strategically "adds" and "removes" air in the work environment. Ventilation can remove or dilute an aircontaminant if designed properly. The design of a ventilation system must match the particular process and chemical orcontaminant in use.Employers may need to use multiple types of controls to prevent employee overexposure.

Local exhaust ventilation usually required. If risk of overexposure exists, wear approved respirator. Correct fit is essential toobtain adequate protection. Supplied-air type respirator may be required in special circumstances. Correct fit is essential toensure adequate protection.An approved self contained breathing apparatus (SCBA) may be required in some situations.Provide adequate ventilation in warehouse or closed storage area. Air contaminants generated in the workplace possessvarying "escape" velocities which, in turn, determine the "capture velocities" of fresh circulating air required to effectivelyremove the contaminant.

Type of Contaminant: Air Speed:

solvent, vapours, degreasing etc., evaporating from tank (in still air).0.25-0.5 m/s(50-100 f/min.)

Chemwatch: 80-2944

Version No: 2.1.1.1

Page 5 of 14

BIOSPERSE 535C

Issue Date: 05/05/2017

Print Date: 04/07/2017

Continued...

Page 6: BIOSPERSE 535C - Cooling Tower Services NZ Ltd 535C.pdfUrgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following

aerosols, fumes from pouring operations, intermittent container filling, low speed conveyer transfers,welding, spray drift, plating acid fumes, pickling (released at low velocity into zone of activegeneration)

0.5-1 m/s(100-200 f/min.)

direct spray, spray painting in shallow booths, drum filling, conveyer loading, crusher dusts, gasdischarge (active generation into zone of rapid air motion)

1-2.5 m/s(200-500 f/min.)

grinding, abrasive blasting, tumbling, high speed wheel generated dusts (released at high initial velocityinto zone of very high rapid air motion).

2.5-10 m/s(500-2000 f/min.)

Within each range the appropriate value depends on:

 Lower end of the range Upper end of the range

1: Room air currents minimal or favourable to capture 1: Disturbing room air currents

2: Contaminants of low toxicity or of nuisance value only. 2: Contaminants of high toxicity

3: Intermittent, low production. 3: High production, heavy use

4: Large hood or large air mass in motion 4: Small hood-local control only

Simple theory shows that air velocity falls rapidly with distance away from the opening of a simple extraction pipe. Velocitygenerally decreases with the square of distance from the extraction point (in simple cases). Therefore the air speed at theextraction point should be adjusted, accordingly, after reference to distance from the contaminating source. The air velocityat the extraction fan, for example, should be a minimum of 1-2 m/s (200-400 f/min) for extraction of solvents generated in atank 2 meters distant from the extraction point. Other mechanical considerations, producing performance deficits within theextraction apparatus, make it essential that theoretical air velocities are multiplied by factors of 10 or more when extractionsystems are installed or used.

Personal protection

Eye and faceprotection

Safety glasses with side shields.Chemical goggles.Contact lenses may pose a special hazard; soft contact lenses may absorb and concentrate irritants. A written policydocument, describing the wearing of lenses or restrictions on use, should be created for each workplace or task. This shouldinclude a review of lens absorption and adsorption for the class of chemicals in use and an account of injury experience.Medical and first-aid personnel should be trained in their removal and suitable equipment should be readily available. In theevent of chemical exposure, begin eye irrigation immediately and remove contact lens as soon as practicable. Lens shouldbe removed at the first signs of eye redness or irritation - lens should be removed in a clean environment only afterworkers have washed hands thoroughly. [CDC NIOSH Current Intelligence Bulletin 59], [AS/NZS 1336 or nationalequivalent]

Skin protection See Hand protection below

Hands/feet protection

Wear chemical protective gloves, e.g. PVC. Wear safety footwear or safety gumboots, e.g. Rubber 

NOTE:The material may produce skin sensitisation in predisposed individuals. Care must be taken, when removing gloves andother protective equipment, to avoid all possible skin contact. Contaminated leather items, such as shoes, belts and watch-bands should be removed and destroyed. 

The selection of suitable gloves does not only depend on the material, but also on further marks of quality which vary frommanufacturer to manufacturer. Where the chemical is a preparation of several substances, the resistance of the glovematerial can not be calculated in advance and has therefore to be checked prior to the application.The exact break through time for substances has to be obtained from the manufacturer of the protective gloves and has tobe observed when making a final choice.Personal hygiene is a key element of effective hand care. Gloves must only be worn on clean hands. After using gloves,hands should be washed and dried thoroughly. Application of a non-perfumed moisturizer is recommended.Suitability and durability of glove type is dependent on usage. Important factors in the selection of gloves include:

·         frequency and duration of contact,·         chemical resistance of glove material,·         glove thickness and·         dexterity

Select gloves tested to a relevant standard (e.g. Europe EN 374, US F739, AS/NZS 2161.1 or national equivalent).·         When prolonged or frequently repeated contact may occur, a glove with a protection class of 5 or higher(breakthrough time greater than 240 minutes according to EN 374, AS/NZS 2161.10.1 or national equivalent) isrecommended.·         When only brief contact is expected, a glove with a protection class of 3 or higher (breakthrough time greaterthan 60 minutes according to EN 374, AS/NZS 2161.10.1 or national equivalent) is recommended.·         Some glove polymer types are less affected by movement and this should be taken into account whenconsidering gloves for long-term use.·         Contaminated gloves should be replaced.

For general applications, gloves with a thickness typically greater than 0.35 mm, are recommended.It should be emphasised that glove thickness is not necessarily a good predictor of glove resistance to a specific chemical,as the permeation efficiency of the glove will be dependent on the exact composition of the glove material. Therefore, glove

Chemwatch: 80-2944

Version No: 2.1.1.1

Page 6 of 14

BIOSPERSE 535C

Issue Date: 05/05/2017

Print Date: 04/07/2017

Continued...

Page 7: BIOSPERSE 535C - Cooling Tower Services NZ Ltd 535C.pdfUrgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following

selection should also be based on consideration of the task requirements and knowledge of breakthrough times.Glove thickness may also vary depending on the glove manufacturer, the glove type and the glove model. Therefore, themanufacturers’ technical data should always be taken into account to ensure selection of the most appropriate glove for thetask.Note: Depending on the activity being conducted, gloves of varying thickness may be required for specific tasks. Forexample:

·         Thinner gloves (down to 0.1 mm or less) may be required where a high degree of manual dexterity is needed.However, these gloves are only likely to give short duration protection and would normally be just for single useapplications, then disposed of.·         Thicker gloves (up to 3 mm or more) may be required where there is a mechanical (as well as a chemical) riski.e. where there is abrasion or puncture potential

Gloves must only be worn on clean hands. After using gloves, hands should be washed and dried thoroughly. Application of anon-perfumed moisturiser is recommended.

Body protection See Other protection below

Other protection

Overalls. P.V.C. apron. Barrier cream. Skin cleansing cream. Eye wash unit. 

Thermal hazards Not Available

Recommended material(s)

GLOVE SELECTION INDEX

Glove selection is based on a modified presentation of the:

 "Forsberg Clothing Performance Index". The effect(s) of the following substance(s) are taken into account in the

 computer-generated selection:          BIOSPERSE 535C

Material CPI

BUTYL C

NATURAL RUBBER C

NEOPRENE C

PVA C

VITON C

* CPI - Chemwatch Performance IndexA: Best SelectionB: Satisfactory; may degrade after 4 hours continuous immersionC: Poor to Dangerous Choice for other than short term immersion

NOTE: As a series of factors will influence the actual performance of theglove, a final selection must be based on detailed observation. -* Where the glove is to be used on a short term, casual or infrequentbasis, factors such as "feel" or convenience (e.g. disposability), maydictate a choice of gloves which might otherwise be unsuitable followinglong-term or frequent use. A qualified practitioner should be consulted.

Respiratory protectionType AB-P Filter of sufficient capacity. (AS/NZS 1716 & 1715, EN143:2000 & 149:2001, ANSI Z88 or national equivalent)

Where the concentration of gas/particulates in the breathing zone,approaches or exceeds the "Exposure Standard" (or ES), respiratoryprotection is required.Degree of protection varies with both face-piece and Class of filter; thenature of protection varies with Type of filter.

RequiredMinimumProtection Factor

Half-FaceRespirator

Full-FaceRespirator

Powered AirRespirator

up to 10 x ES AB-AUS P2 -AB-PAPR-AUS /Class 1 P2

up to 50 x ES -AB-AUS /Class 1 P2

-

up to 100 x ES - AB-2 P2 AB-PAPR-2 P2 ^

^ - Full-faceA(All classes) = Organic vapours, B AUS or B1 = Acid gasses, B2 = Acidgas or hydrogen cyanide(HCN), B3 = Acid gas or hydrogen cyanide(HCN),E = Sulfur dioxide(SO2), G = Agricultural chemicals, K = Ammonia(NH3),Hg = Mercury, NO = Oxides of nitrogen, MB = Methyl bromide, AX = Lowboiling point organic compounds(below 65 degC)

Cartridge respirators should never be used for emergency ingress or inareas of unknown vapour concentrations or oxygen content. The wearermust be warned to leave the contaminated area immediately on detectingany odours through the respirator. The odour may indicate that the mask isnot functioning properly, that the vapour concentration is too high, or thatthe mask is not properly fitted. Because of these limitations, onlyrestricted use of cartridge respirators is considered appropriate.

SECTION 9 PHYSICAL AND CHEMICAL PROPERTIES

Information on basic physical and chemical properties

Appearance Clear liquid with pungent odour; mixes with water.

Physical state LiquidRelative density

(Water = 1)Not Available

Odour Not AvailablePartition coefficient

n-octanol / waterNot Available

Odour threshold Not AvailableAuto-ignition

temperature (°C)Not Available

Chemwatch: 80-2944

Version No: 2.1.1.1

Page 7 of 14

BIOSPERSE 535C

Issue Date: 05/05/2017

Print Date: 04/07/2017

Continued...

Page 8: BIOSPERSE 535C - Cooling Tower Services NZ Ltd 535C.pdfUrgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following

pH (as supplied) 4.2Decomposition

temperatureNot available.

Melting point /freezing point (°C)

Not Available Viscosity (cSt) Not Available

Initial boiling pointand boiling range (°C)

Not AvailableMolecular weight

(g/mol)Not Applicable

Flash point (°C) Not Applicable Taste Not Available

Evaporation rate Not Available Explosive properties Not Available

Flammability Not Applicable Oxidising properties Not Available

Upper Explosive Limit(%)

Not ApplicableSurface Tension

(dyn/cm or mN/m)Not Available

Lower Explosive Limit(%)

Not ApplicableVolatile Component

(%vol)Not Available

Vapour pressure (kPa) Not Available Gas group Not Available

Solubility in water(g/L)

Miscible pH as a solution (1%) Not Available

Vapour density (Air =1)

Not Applicable VOC g/L Not Available

SECTION 10 STABILITY AND REACTIVITY

Reactivity See section 7

Chemical stabilityUnstable in the presence of incompatible materials.Product is considered stable.Hazardous polymerisation will not occur.

Possibility ofhazardous reactions

See section 7

Conditions to avoid See section 7

Incompatible materials See section 7

Hazardousdecomposition

productsSee section 5

SECTION 11 TOXICOLOGICAL INFORMATION

Information on toxicological effects

InhaledInhalation of vapours or aerosols (mists, fumes), generated by the material during the course of normal handling, may bedamaging to the health of the individual.

IngestionAccidental ingestion of the material may be harmful; animal experiments indicate that ingestion of less than 150 gram maybe fatal or may produce serious damage to the health of the individual.

Skin Contact

Skin contact with the material may be harmful; systemic effects may result following absorption.Open cuts, abraded or irritated skin should not be exposed to this materialEntry into the blood-stream through, for example, cuts, abrasions, puncture wounds or lesions, may produce systemic injurywith harmful effects. Examine the skin prior to the use of the material and ensure that any external damage is suitablyprotected.

EyeWhen applied to the eye(s) of animals, the material produces severe ocular lesions which are present twenty-four hours ormore after instillation.

Chronic

Practical experience shows that skin contact with the material is capable either of inducing a sensitisation reaction in asubstantial number of individuals, and/or of producing a positive response in experimental animals.There is sufficient evidence to provide a strong presumption that human exposure to the material may result indevelopmental toxicity, generally on the basis of:- clear results in appropriate animal studies where effects have been observed in the absence of marked maternal toxicity, orat around the same dose levels as other toxic effects but which are not secondary non-specific consequences of the othertoxic effects.

BIOSPERSE 535CTOXICITY IRRITATION

Not Available Not Available

tetrakis(hydroxymethyl)phosphoniumsulfate

TOXICITY IRRITATION

Oral (rat) LD50: 248 mg/kg*[2] Eye: moderate-SEVERE *

Chemwatch: 80-2944

Version No: 2.1.1.1

Page 8 of 14

BIOSPERSE 535C

Issue Date: 05/05/2017

Print Date: 04/07/2017

Continued...

Page 9: BIOSPERSE 535C - Cooling Tower Services NZ Ltd 535C.pdfUrgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following

Skin: moderate-SEVERE *

waterTOXICITY IRRITATION

Not Available Not Available

Legend: 1. Value obtained from Europe ECHA Registered Substances - Acute toxicity 2.* Value obtained from manufacturer's SDS. Unless otherwise specified data extracted from RTECS - Register of Toxic Effect of chemical Substances

TETRAKIS(HYDROXYMETHYL)PHOSPHONIUMSULFATE

The following information refers to contact allergens as a group and may not be specific to thisproduct. Contact allergies quickly manifest themselves as contact eczema, more rarely as urticaria orQuincke's oedema. The pathogenesis of contact eczema involves a cell-mediated (T lymphocytes)immune reaction of the delayed type. Other allergic skin reactions, e.g. contact urticaria, involveantibody-mediated immune reactions. The significance of the contact allergen is not simplydetermined by its sensitisation potential: the distribution of the substance and the opportunities forcontact with it are equally important. A weakly sensitising substance which is widely distributed can bea more important allergen than one with stronger sensitising potential with which few individuals comeinto contact. From a clinical point of view, substances are noteworthy if they produce an allergic testreaction in more than 1% of the persons tested.Allergic reactions which develop in the respiratory passages as bronchial asthma or rhinoconjunctivitis,are mostly the result of reactions of the allergen with specific antibodies of the IgE class and belongin their reaction rates to the manifestation of the immediate type. In addition to the allergen-specificpotential for causing respiratory sensitisation, the amount of the allergen, the exposure period and thegenetically determined disposition of the exposed person are likely to be decisive. Factors whichincrease the sensitivity of the mucosa may play a role in predisposing a person to allergy. They maybe genetically determined or acquired, for example, during infections or exposure to irritantsubstances. Immunologically the low molecular weight substances become complete allergens in theorganism either by binding to peptides or proteins (haptens) or after metabolism (prohaptens).Particular attention is drawn to so-called atopic diathesis which is characterised by an increasedsusceptibility to allergic rhinitis, allergic bronchial asthma and atopic eczema (neurodermatitis) which isassociated with increased IgE synthesis.Exogenous allergic alveolitis is induced essentially by allergen specific immune-complexes of the IgGtype; cell-mediated reactions (T lymphocytes) may be involved. Such allergy is of the delayed typewith onset up to four hours following exposure. for acid mists, aerosols, vapoursData from assays for genotoxic activity in vitro suggest that eukaryotic cells are susceptible togenetic damage when the pH falls to about 6.5. Cells from the respiratory tract have not beenexamined in this respect. Mucous secretion may protect the cells of the airways from direct exposureto inhaled acidic mists, just as mucous plays an important role in protecting the gastric epitheliumfrom its auto-secreted hydrochloric acid. ln considering whether pH itself induces genotoxic events invivo in the respiratory system, comparison should be made with the human stomach, in which gastricjuice may be at pH 1-2 under fasting or nocturnal conditions, and with the human urinary bladder, inwhich the pH of urine can range from <5 to > 7 and normally averages 6.2. Furthermore, exposures tolow pH in vivo differ from exposures in vitro in that, in vivo, only a portion of the cell surface issubjected to the adverse conditions, so that perturbation of intracellular homeostasis may bemaintained more readily than in vitro.for tetrakis(hydroxymethyl)phosphonium salts (THPS):Tetrakis(hydroxymethyl) phosphonium salts represent the major class of chemicals used as a flameretardant for cotton, cellulose and cellulose-blend fabrics. There is low migration from fabrics treatedwith tetrakis(hydroxymethyl) phosphonium chloride (THPC)-urea. The sulfate salt (THPS) is mainlyused as a biocide.A metabolism study on rats has been conducted using 14C-radiolabelled THPS. THPS was not foundin rat urine. However, three metabolites were present, identified as trihydroxymethyl phosphine oxide,bishydroxymethylphosphonic acid and possibly a formaldehyde adduct of the trihydroxy compound.

Short term exposure: In short-term (up to 28 days) studies in rats and mice, the main toxic effectfor both THPC and THPS is decreased body weight. The NOAEL for both chemicals in both species isapproximately 8 mg/kg body weight per day. In longer-term studies (13 weeks), the main target organfor toxicity is the liver. The NOAEL for this effect ranged from 3 to 7 mg/kg body weight per day forboth salts in both species. 

Organs: Carcinogenicity bioassays on THPC also showed effects on the liver, but a NOAEL was notestablished. The LOAEL was approximately 3 mg/kg body weight per day for both species. In acarcinogenicity bioassay on THPS in mice, the NOAEL for focal hyperplasia in the adrenal medullawas 3.6 mg/kg body weight per day; in rats the LOAEL for mortality was 3.6 mg/kg body weight perday. 

Dermal and Ocular effects: THPS did not cause skin irritation when administered as a single dose torabbits. However repeated dermal exposure of rats resulted in severe skin reaction. THPC-urea wascorrosive. THPS was identified as severe eye irritant in rabbits. THPS and THPC-urea cause skinsensitization guinea-pigs (Magnusson & Kilman Maximization test). 

Embryotoxicity: THPS and THPC-urea did not cause developmental toxicity in orally dosedexperimental animals. From these studies a NOAEL of 18 mg/kg body weight per day based on

Chemwatch: 80-2944

Version No: 2.1.1.1

Page 9 of 14

BIOSPERSE 535C

Issue Date: 05/05/2017

Print Date: 04/07/2017

Continued...

Page 10: BIOSPERSE 535C - Cooling Tower Services NZ Ltd 535C.pdfUrgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following

Legend: – Data available but does not fill the criteria for classification – Data available to make classification – Data Not Available to make classification

maternal toxicity could be derived. No developmental effects were observed in the absence ofmaternal toxicity although high doses produced eye malformations in the foetuses of New Zealandwhite rabbits., and produced extra thoraco-lumbar ribs in the foetuses of Charles River CD rats.

Mutagenicity: THPC and THPS have mutagenic potential in vitro, but THPS is not mutagenic invivo (no in vivo mutagenicity data are available for THPC). Limited mutagenicity data for THPC-ureasuggest that it is not mutagenic in vivo. THPO is non-genotoxic. There is no convincing evidence tosuggest that fabrics treated with THP salts are mutagenic. Available information indicates that there isno genotoxic hazard to humans. 

Carcinogenicity: THPC and THPS were not carcinogenic in rats and mice in 2-year bioassays.Dermal studies have shown that THP salts are promoters of skin cancer but not initiators. 

Cholinesterase activity: THPS and THPO did not inhibit acetylchlolinesterase activity invitro, suggesting a lack of neurotoxic hazard for humans. THPC-urea-treated fabric did not cause skinirritation in humans. 

Asthma-like symptoms may continue for months or even years after exposure to the materialceases. This may be due to a non-allergenic condition known as reactive airways dysfunctionsyndrome (RADS) which can occur following exposure to high levels of highly irritating compound.Key criteria for the diagnosis of RADS include the absence of preceding respiratory disease, in anon-atopic individual, with abrupt onset of persistent asthma-like symptoms within minutes to hours ofa documented exposure to the irritant. A reversible airflow pattern, on spirometry, with the presence ofmoderate to severe bronchial hyperreactivity on methacholine challenge testing and the lack ofminimal lymphocytic inflammation, without eosinophilia, have also been included in the criteria fordiagnosis of RADS. RADS (or asthma) following an irritating inhalation is an infrequent disorder withrates related to the concentration of and duration of exposure to the irritating substance. Industrialbronchitis, on the other hand, is a disorder that occurs as result of exposure due to highconcentrations of irritating substance (often particulate in nature) and is completely reversible afterexposure ceases. The disorder is characterised by dyspnea, cough and mucus production.The substance is classified by IARC as Group 3:

NOT classifiable as to its carcinogenicity to humans.Evidence of carcinogenicity may be inadequate or limited in animal testing.Oral (rat) TDLo: 650 mg/kg/13W-I * Petrolite

WATER No significant acute toxicological data identified in literature search. 

Acute Toxicity Carcinogenicity

SkinIrritation/Corrosion

Reproductivity

Serious EyeDamage/Irritation

STOT - SingleExposure

Respiratory or Skinsensitisation

STOT - RepeatedExposure

Mutagenicity Aspiration Hazard

SECTION 12 ECOLOGICAL INFORMATION

Toxicity

BIOSPERSE 535C

ENDPOINT TEST DURATION (HR) SPECIES VALUE SOURCE

NotApplicable

Not Applicable Not ApplicableNotApplicable

NotApplicable

tetrakis(hydroxymethyl)phosphoniumsulfate

ENDPOINT TEST DURATION (HR) SPECIES VALUE SOURCE

LC50 96 Fish 94mg/L 4

EC50 48 Crustacea 15mg/L 4

water

ENDPOINT TEST DURATION (HR) SPECIES VALUE SOURCE

LC50 96 Fish 897.520mg/L 3

EC50 96 Algae or other aquatic plants 8768.874mg/L 3

Legend: Extracted from 1. IUCLID Toxicity Data 2. Europe ECHA Registered Substances - Ecotoxicological Information - AquaticToxicity 3. EPIWIN Suite V3.12 (QSAR) - Aquatic Toxicity Data (Estimated) 4. US EPA, Ecotox database - Aquatic ToxicityData 5. ECETOC Aquatic Hazard Assessment Data 6. NITE (Japan) - Bioconcentration Data 7. METI (Japan) - BioconcentrationData 8. Vendor Data

Chemwatch: 80-2944

Version No: 2.1.1.1

Page 10 of 14

BIOSPERSE 535C

Issue Date: 05/05/2017

Print Date: 04/07/2017

Continued...

Page 11: BIOSPERSE 535C - Cooling Tower Services NZ Ltd 535C.pdfUrgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following

Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. Do NOT allow product to come in contact with surface waters or to intertidal areas below the mean high water mark. Do not contaminate water whencleaning equipment or disposing of equipment wash-waters. Wastes resulting from use of the product must be disposed of on site or at approved waste sites.

DO NOT discharge into sewer or waterways.

Persistence and degradability

Ingredient Persistence: Water/Soil Persistence: Air

water LOW LOW

Bioaccumulative potential

Ingredient Bioaccumulation

water LOW (LogKOW = -1.38)

Mobility in soil

Ingredient Mobility

water LOW (KOC = 14.3)

SECTION 13 DISPOSAL CONSIDERATIONS

Waste treatment methods

Product / Packagingdisposal

DO NOT allow wash water from cleaning or process equipment to enter drains. It may be necessary to collect all wash water for treatment before disposal. In all cases disposal to sewer may be subject to local laws and regulations and these should be considered first. Where in doubt contact the responsible authority. Recycle wherever possible or consult manufacturer for recycling options. Consult State Land Waste Authority for disposal. Bury or incinerate residue at an approved site. Recycle containers if possible, or dispose of in an authorised landfill. 

Ensure that the disposal of material is carried out in accordance with Hazardous Substances (Disposal) Regulations 2001.

SECTION 14 TRANSPORT INFORMATION

Labels Required

Marine Pollutant

HAZCHEM •3Z

Land transport (UN)

UN number 3082

UN proper shippingname

ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S.

Transport hazardclass(es)

Class 9

Subrisk Not Applicable

Packing group III

Environmental hazard Not Applicable

Special precautionsfor user

Special provisions 274; 331; 335; 375

Limited quantity 5 L

Chemwatch: 80-2944

Version No: 2.1.1.1

Page 11 of 14

BIOSPERSE 535C

Issue Date: 05/05/2017

Print Date: 04/07/2017

Continued...

Page 12: BIOSPERSE 535C - Cooling Tower Services NZ Ltd 535C.pdfUrgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following

Air transport (ICAO-IATA / DGR)

UN number 3082

UN proper shippingname

Environmentally hazardous substance, liquid, n.o.s. *

Transport hazardclass(es)

ICAO/IATA Class 9

ICAO / IATA Subrisk Not Applicable

ERG Code 9L

Packing group III

Environmental hazard Not Applicable

Special precautionsfor user

Special provisions A97 A158 A197

Cargo Only Packing Instructions 964

Cargo Only Maximum Qty / Pack 450 L

Passenger and Cargo Packing Instructions 964

Passenger and Cargo Maximum Qty / Pack 450 L

Passenger and Cargo Limited Quantity Packing Instructions Y964

Passenger and Cargo Limited Maximum Qty / Pack 30 kg G

Sea transport (IMDG-Code / GGVSee)

UN number 3082

UN proper shippingname

ENVIRONMENTALLY HAZARDOUS SUBSTANCE, LIQUID, N.O.S.

Transport hazardclass(es)

IMDG Class 9

IMDG Subrisk Not Applicable

Packing group III

Environmental hazard Marine Pollutant

Special precautionsfor user

EMS Number F-A , S-F

Special provisions 274 335 969

Limited Quantities 5 L

Transport in bulk according to Annex II of MARPOL and the IBC codeNot Applicable

SECTION 15 REGULATORY INFORMATION

Safety, health and environmental regulations / legislation specific for the substance or mixtureThis substance is to be managed using the conditions specified in an applicable Group Standard

HSR Number Group Standard

HSR002684 Water Treatment Chemicals (Subsidiary Hazard) Group Standard 2006

TETRAKIS(HYDROXYMETHYL)PHOSPHONIUM SULFATE(55566-30-8) IS FOUND ON THE FOLLOWING REGULATORY LISTS

International Agency for Research on Cancer (IARC) - Agents Classifiedby the IARC Monographs

New Zealand Hazardous Substances and New Organisms (HSNO) Act -Classification of Chemicals

New Zealand Inventory of Chemicals (NZIoC)

WATER(7732-18-5) IS FOUND ON THE FOLLOWING REGULATORY LISTS

New Zealand Inventory of Chemicals (NZIoC)

Location Test CertificateSubject to Regulation 55 of the Hazardous Substances (Classes 1 to 5 Controls) Regulations, a location test certificate is required when quantity greaterthan or equal to those indicated below are present.

Hazard ClassQuantity beyond which controls apply for closedcontainers

Quantity beyond which controls apply when use occurring inopen containers

Chemwatch: 80-2944

Version No: 2.1.1.1

Page 12 of 14

BIOSPERSE 535C

Issue Date: 05/05/2017

Print Date: 04/07/2017

Continued...

Page 13: BIOSPERSE 535C - Cooling Tower Services NZ Ltd 535C.pdfUrgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following

Not Applicable Not Applicable Not Applicable

Approved HandlerSubject to Regulation 56 of the Hazardous Substances (Classes 1 to 5 Controls) Regulations and  Regulation 9 of the Hazardous Substances (Classes 6,8, and 9 Controls) Regulations, the substance must be under the personal control of an Approved Handler when present  in a quantity greater than orequal to those indicated below.

Class of substance Quantities

9.1A, 9.2A, 9.3A, and9.4A

Any quantity

Refer Group Standards for further information

Tracking RequirementsSubject to Hazardous Substances (Tracking) Regulation 2001- Refer to the regulation for more information

National Inventory Status

Australia - AICS Y

Canada -  DSL Y

Canada - NDSL N (water; tetrakis(hydroxymethyl)phosphonium sulfate)

China - IECSC Y

Europe - EINEC /ELINCS / NLP

Y

Japan - ENCS N (tetrakis(hydroxymethyl)phosphonium sulfate)

Korea - KECI Y

New Zealand - NZIoC Y

Philippines - PICCS Y

USA - TSCA Y

Legend:Y = All ingredients are on the inventoryN = Not determined or one or more ingredients are not on the inventory and are not exempt from listing(see specific ingredientsin brackets)

SECTION 16 OTHER INFORMATION

Other information

Ingredients with multiple cas numbers

Name CAS No

tetrakis(hydroxymethyl)phosphoniumsulfate

55566-30-8, 58591-11-0, 65257-04-7

Classification of the preparation and its individual components has drawn on official and authoritative sources as well as independent review by theChemwatch Classification committee using available literature references.

The SDS is a Hazard Communication tool and should be used to assist in the Risk Assessment. Many factors determine whether the reported Hazards areRisks in the workplace or other settings. Risks may be determined by reference to Exposures Scenarios. Scale of use, frequency of use and current oravailable engineering controls must be considered.

Definitions and abbreviationsPC-TWA: Permissible Concentration-Time Weighted AveragePC-STEL: Permissible Concentration-Short Term Exposure LimitIARC: International Agency for Research on CancerACGIH: American Conference of Governmental Industrial HygienistsSTEL: Short Term Exposure LimitTEEL: Temporary Emergency Exposure Limit。IDLH: Immediately Dangerous to Life or Health ConcentrationsOSF: Odour Safety FactorNOAEL :No Observed Adverse Effect LevelLOAEL: Lowest Observed Adverse Effect LevelTLV: Threshold Limit ValueLOD: Limit Of DetectionOTV: Odour Threshold ValueBCF: BioConcentration Factors

Chemwatch: 80-2944

Version No: 2.1.1.1

Page 13 of 14

BIOSPERSE 535C

Issue Date: 05/05/2017

Print Date: 04/07/2017

Continued...

Page 14: BIOSPERSE 535C - Cooling Tower Services NZ Ltd 535C.pdfUrgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following

BEI: Biological Exposure Index

This document is copyright.Apart from any fair dealing for the purposes of private study, research, review or criticism, as permitted under the Copyright Act, no part may bereproduced by any process without written permission from CHEMWATCH.TEL (+61 3) 9572 4700.

Chemwatch: 80-2944

Version No: 2.1.1.1

Page 14 of 14

BIOSPERSE 535C

Issue Date: 05/05/2017

Print Date: 04/07/2017

end of SDS